Press Releases
Groundbreaking Study Employing Sensonics International’s Products Reveals Weight Loss Medications Impair Taste Function
PHILADELPHIA, Jan. 30, 2025 /PRNewswire/ -- A new study published in Physiology & Behavior uncovers significant sensory implications of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), medications commonly prescribed for weight
